I know the reopening trade idea is in play right now but how strong is the sentiment? We still need stimulus to come out, more vaccines, more everything. So where does AHT go from here? Fibs look interesting too. NYSE:AHT Aside from the industry sentiment, Ashford has been fundamentally making strides in preparation for a hopefully bullish return to the...
I know we saw a strong day today but here it is at a frequent technical level it has had a hard time breaking above before. Can it do it again? This is where we’ve seen stocks like LKCO NASDAQ:LKCO surge this year. If you look back at the start of 2021, the penny stock was trading around $0.70 and ended up rallying as high as $3.86 last month. Similar to many...
Shares of QEP also surged on Thursday, which continued a multi-month rally that began in late-October. In fact, since October 3th, QEP stock has climbed nearly 350% so far. It also reached a fresh, 52-week high of $4.13. The strength in the underlying oil and gas industry has helped propel momentum in the stock for months. Biggest question might be what happens...
Shares of WTI stock shot up huge on Thursday. This move came just a day after the company reported its latest earnings results. The oil and gas company beat on both EPS and sales. Most notably, W&T reported a loss per share of 5 cents. Though this was the case, the same year-ago period saw a loss per share of 31 cents. Sales came in at $94.75 million compared to...
"In its Q4 report posted a week or so ago, the company managed to increase its liquidity to $340 million from $297 million in the previous year. Given that CDEV stock is heavily tied to the energy industry, it is also undoubtedly correlated to the pandemic. Because the pandemic has resulted in a massive dive in energy consumption, Centennial has had to work hard...
Technical levels line up from previous areas of resistance. Does IDEX have enough juice to continue this rebound? Big question mark there but with surges in EV penny stocks, sympathy momentum could play a role. Of all of its endeavors, I actually am starting to like this tractor play. I didn't know these were actually industrial-style tractors. As far as...
"Shares of this cheap stock managed to make a move from just $0.26 on November 30th to highs of over $0.55 this week. Volume has also become a focus recently too as the second half of December saw some of the highest daily trading volumes of the 3rd and 4th quarters. What has been going on with ONTX? Last month, Onconova received permission from the FDA to study...
Looking at the Fibs, DS is once again testing this technical level. It's been a decently strong level of resistance for months. Only was able to break above it briefly but couldn't sustain itself for more than a few days. With the vaccine set for delivery in this week, it's going to be interesting to see how epicenter stocks perform. Will we finally get that...
It Will be interesting to see how AXAS performs this coming week now that Pfizer's vaccine is set to ship. Energy stocks will likely be a focus and might be worth watching at the very least. "Investors should be watching these companies due to their relationship with the covid vaccine. If a vaccine comes out in a timely manner, it could mean more people out...
No news Friday but another day of higher volume. What's happening with GNUS right now? "The move comes on the heels of a few key updates. Toward the end of September, Genius inked a deal with Samsung for its Kartoon Channel! to be carried across Samsung’s Smart TVs. The company has also been licensing new content to feature in its digital lineup. While there...
ALRN had some weekend news. Will be interesting to see if it can break above a near-two-year resistance level. I didn't show it all the way back to November of 2018 but if you take the chart out further, you can see this level holding as resistance. "Saturday, the company announced new positive clinical data from its ongoing Phase 1b trial. The trial...
MGEN has been getting hammered lately. Not one single green close in the last few weeks. Friday was the first, somewhat green close and that ain't saying much. But trading action was interesting. "riday’s action was something much different than what the penny stock had seen during the 2 weeks prior. It was the first trading day that MGEN shares didn’t close...
MARK made a tweet with a video on Friday all in a foreign language. Tagged Intel. No PR (yet) so is it real or is it another hype play like it's done before? "This would obviously be big news for any company of Remark’s size. However, it’s important to remember that a deal might also correspond with a filing and/or press release. So far, since the tweet came out...
INUV continued trading after hours on Friday. Interesting volume in the last 4 sessions. "Inuvo filed the annual meeting of shareholders proxy giving a record date of October 26th for eligible voters. Among the topics to vote on, Inuvo would like to increase its authorized share count to 150 million from 100 million. Many times, companies will do this with a...
AXGT is back at another area of support/resistance. Friday will be another day to keep in mind in light of the company's event. There will be additional data and program updates at its Parkinson’s disease R&D Day on Friday. Remember what was also said originally with this particular trial “These data, showing over 20 points of improvement on the UPDRS Part III...
CASI saw a nice bump in after-hours trading Friday. Shares hit $1.88. Can the Oppenheimer analyst rating be enough of a catalyst to carry through this momentum into the week ahead is the biggest question. Great volume on Friday but is it all for nothing? "What had sparked some excitement came in light of new analyst activity. Oppenheimer analyst Leland Gershell...
BLU afterhours runner on Friday. Just cashed up a cool $40 mil. But the institutional positions could be a thing to monitor closely. Such a blown out penny stock now getting some attractive institutions posting 13's " After the closing bell on Friday, BLU stock jumped from a close of $2.45 to after-market highs of $2.79. Something else to note is that a 13G was...
SELB filled that gap down from its data miss a few weeks back and now testing a pretty consistent level of previous support/resistance. "Selecta and IGAN Biosciences entered into a research license and option agreement to study Selecta’s ImmTOR™ immune tolerance platform in combination with IGAN’s immunoglobulin A protease for the treatment of IgA Nephropathy....